# Eukairia Therapeutics

> Eukairia Therapeutics is developing a patent-pending Therapeutic Transition Platform that makes medication initiation, titration, tapering and therapeutic substitution simpler for patients and clinicians.

Eukairia Therapeutics is a Charleston, South Carolina pharmaceutical company founded in 2025 by Elizabeth Perkins, MD (Founder, CEO & Inventor). Its products are in development and have not been approved by the FDA or any other regulatory authority.

## Platform
- Therapeutic Transition Platform (patent pending): integrates drug delivery, sequencing and human-centered design within the pharmaceutical product.
- Functions: Initiate, Transition (titration and therapeutic substitution), Taper.

## Program areas
- Treatment initiation
- Dose optimization
- Therapeutic substitution
- Medication tapering
- Dependence and cessation

## Potential applications
Addiction medicine, psychiatry, pain and post-operative care, neurology, chronic disease, other complex medication transitions.

## Contact
- Email: info@eukairiatherapeutics.com
- LinkedIn: https://www.linkedin.com/company/eukairia-therapeutics/

## Pages
- [Home](https://eukairiatherapeutics.com/)
- [Privacy Policy](https://eukairiatherapeutics.com/privacy)
- [Terms of Use](https://eukairiatherapeutics.com/terms)
- [Accessibility](https://eukairiatherapeutics.com/accessibility)